載入中
NASDAQHealthcareMedical - Pharmaceuticals
最新資料
US$8.94
+US$0.33 · +3.83%
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
前收盤價
US$8.94
+US$0.33 · +3.83%
盤後
US$8.94
US$0.00 · 0.00%
10月14日 下午6:31 ET
盤中時間採用ET。市場資料可能有所延遲。
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
日內區間
目前US$8.94
52週區間
目前US$8.94
盤中時間採用ET。市場資料可能有所延遲。
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
日內區間
目前US$8.94
52週區間
目前US$8.94
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$32.00
上漲空間 257.94%報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
